Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3025]
News [6111]
Articles [120]
Editorials [18]
Conferences [179]
elearning [32]
Improving cancer care in the UK
Dr Becks Fisher - The Health Foundation, London, UK
Improving cancer care in the UK ( Dr Becks Fisher - The Health Foundation, London, UK )
13 Jan 2020
Is enasidenib plus azacitidine better than with azacitidine alone for AML...
Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA
Is enasidenib plus azacitidine better than with azacitidine alone for AML patients? ( Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA )
24 Dec 2019
Lenalidomide maintenance for transplant eligible and transplant ineligible...
Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK
Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients ( Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK )
24 Dec 2019
Dasatinib vs imatinib in the treatment of paediatric ALL
Dr Shuhong Shen - National Children's Medical Center, Shanghai, China
Dasatinib vs imatinib in the treatment of paediatric ALL ( Dr Shuhong Shen - National Children's Medical Center, Shanghai, China )
24 Dec 2019
Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women...
Dr Terry Mamounas - Orlando Health UF Health Cancer Center, Orlando, USA
Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women with hormone receptor-positive breast cancer ( Dr Terry Mamounas - Orlando Health UF Health Cancer Center, Orlando, USA )
19 Dec 2019
Cisplatin versus doxorubicin/cyclophosphamide as neoadjuvant treatment in...
Dr Nadine Tung - Beth Israel Deaconess Medical Center, Boston, USA
Cisplatin versus doxorubicin/cyclophosphamide as neoadjuvant treatment in germline BRCA carriers with HER2-negative BC ( Dr Nadine Tung - Beth Israel Deaconess Medical Center, Boston, USA )
19 Dec 2019
Breast cancer screening and treatment in Brazil
Dr Gustavo Werutsky - Latin American Cooperative Oncology Group, Porto Alegre...
Breast cancer screening and treatment in Brazil ( Dr Gustavo Werutsky - Latin American Cooperative Oncology Group, Porto Alegre, Brazil )
19 Dec 2019
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
19 Dec 2019
Oral paclitaxel with encequidar in metastatic breast cancer
Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras
Oral paclitaxel with encequidar in metastatic breast cancer ( Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras )
19 Dec 2019
Pathologic complete response rates improved with the neoadjuvant and adjuvant...
Prof Peter Schmid - St Bartholomew's Hospital London, London, UK
Pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembrolizumab in TNBC patients ( Prof Peter Schmid - St Bartholomew's Hospital London, London, UK )
18 Dec 2019
Combining atezolizumab to neoadjuvant chemotherapy does not improve pathologic...
Dr Luca Gianni - San Raffaele Hospital, Milan, Italy
Combining atezolizumab to neoadjuvant chemotherapy does not improve pathologic complete response rates for TNBC patients ( Dr Luca Gianni - San Raffaele Hospital, Milan, Italy )
18 Dec 2019
Breast cancer prevention in high-risk post-menopausal women
Prof Jack Cuzick - Queen Mary University of London, London, UK
Breast cancer prevention in high-risk post-menopausal women ( Prof Jack Cuzick - Queen Mary University of London, London, UK )
18 Dec 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation